PhotoPill is developing a daily treatment solution, which will be effective in both treating inflammatory outbursts, as well as postponing future episodes.

Concealium is Developing a unique SaaS based Data Centric Security solution that enables protection of Data, wherever it goes.
Trail tracking as well remote enforcement of digital rights are enabled, enabling mobility, collaboration and compliance in a simple, quick and non invasive manner.

Cupola is engaged in the development and commercialization of novel and non-invasive medical devices indicated for Tattoo and Pigment removal.
Cupola targets the Aesthetic market with this innovative solution.

Cmycasa creates a unique photo realistic 3D image of real estate floor plans and integrates them into any website with the greatest of ease.

ENT Surgical is developing a unique technology that will enable the performance of surgical insertion of ventilation tube to the eardrum (Myringotomy), within seconds, through usage of a single, all in one, medical device thus excluding the need for general anesthesia

Mediscale is developing a Software as a Service Based Prenatal Genetic Screening & Practice Management Support System that will lead to dramatic improvements in OB/GYN screening practices, introduce a practice standard data base and enhance EMR/PM capabilities.

CGM-3 is developing a sensor containing implant which will automatically and continuously monitor Glucose levels in Diabetes Type 1 patients, thus bridging the technological gap for an artificial Pancreas omitting Insulin.

GRsee provides visual solutions to the Governance, Risk & Compliance (GRC) market with a first of its kind Governance IT solution.

Conic-IT is developing an innovative and non-invasive software platform, that enables enterprises to significantly improve their application and system performance.

Intratech medical is developing a novel solution for the treatment of Ischemic Stroke

JetPrep is engaged in the development and marketing of innovative medical devices for the Gastrointestinal (GI) market.

Cellergy has developed a new method of producing an electrochemical double layer capacitor, which results in a passive component that is flexible in size, voltage and power. This process significantly lowers production costs compared to existing technologies, while the design of Cellergy's capacitors results in better performance – the low equivalent series resistance and high capacitance allows delivery of high pulse current, enabling reduction of the voltage drop in battery-operated applications or a power boost for backup.

Remon Medical Technologies develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. Remon's unique platform has broad applications for patient management. Remon Medical is backed by leading global investors including Concord Ventures, KBL Healthcare Ventures, Lilly Ventures, Medica Venture Partners, Ofer Hi-Tech, Polaris Venture Partners, Triathlon Medical Ventures, and Guidant Corporation.

Checkmarx offers accurate and effective solutions to ensure software security.

EZSurgical develops innovative surgical tools aiming to assist the surgeon while performing general and minimal invasive (MIS) procedures.

Mentorwave provides a comprehensive site visualization solution, enabling users to actually navigate, explore and visit real locations in a robust virtual environment. Its technology, MENTORIA, produces state-of–the-art, high-quality scanned images with its proprietary hardware, authoring system and tools. www.mentorwave.com

CogniFit develops state-of-the-art applications that assess, train and enhance cognitive and psychomotor abilities. CogniFit's goal is to become a world leader in the development of unique applications in the field.

EndoCross is developing a breakthrough technology for treating vascular occlusions.

Arbel Medical develops the next generation of Cryosurgery products and focuses first on the office-based treatment

NextNine has revolutionized the way large-scale, enterprise-wide mission-critical systems are supported and serviced through the introduction of a new paradigm of automated remote customer support and adaptive service solutions.

CoreFlow develops, manufactures and markets innovative aeromechanical OEM subsystems that enhance the performance of factory automation equipment in the semiconductor, flat panel display and printed circuit board industries as well as in the printing machine sector.

AngioSlide is developing a breakthrough platform technology that both improves existing procedures and opens new applications in the field of interventional cardiology.

Tevet Process Control Technologies provides the semiconductor processing industry with superior integrated metrology solutions for improved process control technologies. The company has identified real-time, in-situ or integrated metrology as a key building block for the optimal advanced process control loop.

CorAssist is developing innovative therapeutic products for the treatment of diastolic heart failure. The company's platform technology, the ImCardia™ device, enables the first implantation of a device that directly improves cardiac diastolic function.

NanoPass develops highly competitive, painless MicroPyramid™ devices for drug delivery and diagnostics, which use the most advanced MEMS (micro electro-mechanical systems) bioengineering, as is used in silicon wafer micro-fabrication.

M.G.V. Systems is developing therapeutic protocols based on unique technologies involving the transfer of specific genes to vascular cells. This novel therapeutic protocol will provide effective treatment for patients who are beyond cure today.

THROMBOTECH is developing a series of new and improved thrombolytic agents that can easily dissolve newly formed blood clots without side effects. These new and innovative protocols can treat patients who previously had no treatment (stroke victims) and offer a better and safer mode of therapy for heart attack (acute myocardial infarction).

Enzymotec creates tailor-made and unique biocatalysts for enzymatic processes, yielding higher quality products and lower processing costs. The company’s patented AMIET® technology represents a breakthrough technological platform, which enhances any enzyme and enables it to efficiently perform in an organic media.

Barnev’s Computerized Labor Monitoring System, the CLM, enables obstetricians to make critical decisions based on accurate and timely information, resulting in significantly improved medical care, reduced costs and a lower risk of malpractice.

Common Sense Ltd. develops and manufactures nonintrusive home tests for classification of common abnormal vaginal discharges (the VI-SENSE Kit) and for detection of amniotic fluid leakage (the AL-SENSE Kit). Both products have received CE certification and are marketed throughout Europe.

NoriTech Seaweed Biotechnologies Ltd. is developing a revolutionary technology for the commercial cultivation of the edible seaweed Porphyra ("Nori") in on-land seawater ponds. The economic benefits of NoriTech's controlled cultivation system are its reliability in producing a pre-planned, standardized crop and its ability to enrich the algae with nutritional elements.

TK-Signal is developing revolutionary radiology-based compounds for diagnosing, monitoring and treating cancer. The company’s highly selective radioactive tracers are used in conjunction with nuclear medicine imaging techniques (PET) to specifically target the epidermal growth factor receptor.

Verto Medical is a biopharmaceutical company focused on the research and development of highly specific therapeutic products for the treatment of Systemic Lupus Erythematosus, a life-threatening antibody mediated disease.